Board grants faculty tenure
At the WashU Board of Trustees meeting Sept. 27, numerous faculty members were granted tenure, effective that day.
Immunotherapy blocks scarring, improves heart function in mice with heart failure
A new study from WashU Medicine researchers finds that a type of immunotherapy — similar to one approved by the FDA to treat inflammatory conditions — may be an effective treatment strategy for heart failure.
Gladney appointed interim vice chancellor, chief HR officer
Apryle M. Gladney has been appointed interim vice chancellor and chief human resources officer at WashU, announced Nichol Luoma, executive vice chancellor and chief administrative officer. Her new role took effect Oct. 15.
HLC accreditation open forums set for Oct. 28, 29
As part of WashU’s 10-year comprehensive evaluation, the Higher Learning Commission, the institutional accreditor, will host three open forums Oct. 28 and 29 to gather input from faculty, staff and students.
Frantz appointed vice chancellor for innovation, commercialization
Doug E. Frantz has been appointed the new vice chancellor for innovation and commercialization at WashU, effective Jan. 1, according to Chancellor Andrew D. Martin and David H. Perlmutter, MD, executive vice chancellor for medical affairs and dean of the School of Medicine.
Information security policies updated
WashU’s Office of Information Security has recently revised and updated its policies to keep pace with the evolving digital landscape.
East entrance to Central West End MetroLink station to temporarily close
The east entrance and walkway connecting the Central West End MetroLink station platform with bus bays at the transit center, near the Medical Campus, will temporarily close at 6 p.m. Thursday, Oct. 17. They will reopen Monday, Oct. 21.
Flu shots available for employees
Occupational Health Services is holding free on-site flu vaccine clinics for WashU employees on both the Danforth and Medical campuses. Flu shots will take place on the Danforth Campus Oct. 7-11.
Viruses found hiding in lungs’ immune cells long after initial illness
A mouse study by researchers at WashU Medicine shows that lingering respiratory viruses set the stage for chronic lung disease, and eliminating infected cells reduces signs of chronic lung damage.
View More Stories